Luan D. Vu

582 total citations
16 papers, 343 citations indexed

About

Luan D. Vu is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Luan D. Vu has authored 16 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Luan D. Vu's work include Respiratory viral infections research (8 papers), Neonatal Respiratory Health Research (5 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Luan D. Vu is often cited by papers focused on Respiratory viral infections research (8 papers), Neonatal Respiratory Health Research (5 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Luan D. Vu collaborates with scholars based in United States, Australia and Argentina. Luan D. Vu's co-authors include Stephania A. Cormier, Dahui You, David Siefker, John P. DeVincenzo, Diego R. Hijano, Fernando P. Polack, Lawrence M. Kauvar, Ralph A. Tripp, Tamekia L. Jones and Jeffrey N. Harding and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Luan D. Vu

15 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luan D. Vu United States 9 194 110 102 102 62 16 343
M Huerre France 8 123 0.6× 236 2.1× 69 0.7× 49 0.5× 52 0.8× 18 416
Stefan Löseke Germany 7 91 0.5× 74 0.7× 123 1.2× 40 0.4× 77 1.2× 12 318
Stéfanie Primon Muraro Brazil 8 147 0.8× 224 2.0× 95 0.9× 127 1.2× 135 2.2× 15 430
Tao Bian China 10 149 0.8× 69 0.6× 56 0.5× 39 0.4× 102 1.6× 24 336
Ryuta Takizawa Japan 8 190 1.0× 163 1.5× 128 1.3× 43 0.4× 39 0.6× 19 410
Sabelo Hadebe South Africa 10 92 0.5× 157 1.4× 46 0.5× 130 1.3× 69 1.1× 15 357
Emilie Dalloneau France 10 76 0.4× 63 0.6× 65 0.6× 48 0.5× 89 1.4× 11 293
Punnam Chander Veerati Australia 10 79 0.4× 97 0.9× 125 1.2× 34 0.3× 63 1.0× 14 319
Maria P. White United States 10 114 0.6× 132 1.2× 65 0.6× 44 0.4× 33 0.5× 16 292
William Domm United States 9 130 0.7× 94 0.9× 69 0.7× 62 0.6× 74 1.2× 13 327

Countries citing papers authored by Luan D. Vu

Since Specialization
Citations

This map shows the geographic impact of Luan D. Vu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luan D. Vu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luan D. Vu more than expected).

Fields of papers citing papers by Luan D. Vu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luan D. Vu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luan D. Vu. The network helps show where Luan D. Vu may publish in the future.

Co-authorship network of co-authors of Luan D. Vu

This figure shows the co-authorship network connecting the top 25 collaborators of Luan D. Vu. A scholar is included among the top collaborators of Luan D. Vu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luan D. Vu. Luan D. Vu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sly, Peter D., Keng Yih Chew, Lavrent Khachatryan, et al.. (2023). Environmentally persistent free radicals enhance SARS-CoV-2 replication in respiratory epithelium. Experimental Biology and Medicine. 248(3). 271–279. 6 indexed citations
2.
Cormier, Stephania A., et al.. (2022). Environmental Impacts on COVID-19: Mechanisms of Increased Susceptibility. Annals of Global Health. 88(1). 94–94. 4 indexed citations
3.
Vu, Luan D., Rebecca C. Christofferson, Sean Parker, et al.. (2022). Absence of antibody responses to SARS-CoV-2 N protein in COVID-19 vaccine breakthrough cases. Experimental Biology and Medicine. 247(21). 1923–1936. 1 indexed citations
5.
Vu, Luan D., Jordy Saravia, Sridhar Jaligama, et al.. (2021). Deficiency in ST2 signaling ameliorates RSV-associated pulmonary hypertension. American Journal of Physiology-Heart and Circulatory Physiology. 321(2). H309–H317. 3 indexed citations
6.
Harding, Jeffrey N., David Siefker, Luan D. Vu, et al.. (2020). Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity. BMC Microbiology. 20(1). 140–140. 49 indexed citations
7.
Fowlkes, Natalie W., Luan D. Vu, Tatiane Terumi Negrão Watanabe, et al.. (2020). Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Melanoma Model. Journal of Virology. 95(3). 18 indexed citations
9.
Starlard‐Davenport, Athena, et al.. (2019). MIR29B mediates epigenetic mechanisms of HBG gene activation. British Journal of Haematology. 186(1). 91–100. 16 indexed citations
10.
Vu, Luan D., David Siefker, Tamekia L. Jones, et al.. (2019). Elevated Levels of Type 2 Respiratory Innate Lymphoid Cells in Human Infants with Severe Respiratory Syncytial Virus Bronchiolitis. American Journal of Respiratory and Critical Care Medicine. 200(11). 1414–1423. 63 indexed citations
11.
Siefker, David, Luan D. Vu, Dahui You, et al.. (2019). Respiratory Syncytial Virus Disease Severity Is Associated with Distinct CD8+ T-Cell Profiles. American Journal of Respiratory and Critical Care Medicine. 201(3). 325–334. 30 indexed citations
12.
Hijano, Diego R., Luan D. Vu, Lawrence M. Kauvar, et al.. (2019). Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity. Frontiers in Immunology. 10. 566–566. 88 indexed citations
13.
Siefker, David, Luan D. Vu, Dahui You, et al.. (2019). Respiratory syncytial virus disease severity is associated with distinct CD8+ T cell profiles. The Journal of Immunology. 202(1_Supplement). 198.11–198.11. 1 indexed citations
14.
Hijano, Diego R., David Siefker, Bishwas Shrestha, et al.. (2018). Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy. Scientific Reports. 8(1). 11034–11034. 33 indexed citations
15.
Kimura, Dai, Jordy Saravia, Sridhar Jaligama, et al.. (2018). New mouse model of pulmonary hypertension induced by respiratory syncytial virus bronchiolitis. American Journal of Physiology-Heart and Circulatory Physiology. 315(3). H581–H589. 12 indexed citations
16.
Shabani, Shkelzen, et al.. (2007). Acidity enhances the effectiveness of active chemical defensive secretions of sea hares, Aplysia californica, against spiny lobsters, Panulirus interruptus. Journal of Comparative Physiology A. 193(12). 1195–1204. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026